Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

4.875

+0.005 (0.10%)

At close: Dec 5, 2025, 4:00 PM EST

5.00

+0.13 (2.67%)

Pre-market: Dec 8, 2025, 7:32 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2013 - 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2013 - 2017
Gene and Cell Therapies	3.50M	Log In	Log In	Log In	Log In	Upgrade
Gene and Cell Therapies Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2013 - 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2013 - 2017
United States	3.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade